• Product NameMSDC-0160
• Brief DescriptionInhibitors
• Purification99.53%
• Biological ActivityMSDC-0160 is a prototype mTOT-modulating insulin sensitizer being studied to treat diabetes and Alzheimer's disease. Phase 2.
• Target NameOthers
• CAS No. 146062-49-9
• Calculated MW 370.42
• Formulation C19H18N2O4S
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Other
  SMILES:CCC1=CN=C(C=C1)C(=O)COC1=CC=C(CC2SC(=O)NC2=O)C=C1
  Pathways:Others
  Receptor:mTOT
  Boling pt:
  Melting pt:
  Solubility:DMSO: 0.01 mg/mL (0.02 mM)
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Rohatgi N, et al. PLoS One. 2013, 8(5), e62012.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting